SPISANI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 9.355
AS - Asia 4.099
EU - Europa 2.447
SA - Sud America 752
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 16.735
Nazione #
US - Stati Uniti d'America 9.174
SG - Singapore 1.645
CN - Cina 1.278
BR - Brasile 632
UA - Ucraina 598
DE - Germania 579
HK - Hong Kong 389
TR - Turchia 324
GB - Regno Unito 303
IT - Italia 240
VN - Vietnam 238
FI - Finlandia 220
SE - Svezia 156
RU - Federazione Russa 120
MX - Messico 96
FR - Francia 73
CA - Canada 71
IN - India 55
AR - Argentina 47
PL - Polonia 47
ZA - Sudafrica 44
BD - Bangladesh 32
ES - Italia 24
BE - Belgio 23
ID - Indonesia 23
JP - Giappone 23
NL - Olanda 19
IQ - Iraq 17
EC - Ecuador 15
LT - Lituania 15
CL - Cile 13
CO - Colombia 11
PK - Pakistan 11
VE - Venezuela 11
IR - Iran 10
PE - Perù 10
CZ - Repubblica Ceca 7
KE - Kenya 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
SA - Arabia Saudita 6
CH - Svizzera 4
EG - Egitto 4
EU - Europa 4
OM - Oman 4
UZ - Uzbekistan 4
AT - Austria 3
BO - Bolivia 3
GE - Georgia 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
MK - Macedonia 2
PS - Palestinian Territory 2
RO - Romania 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GI - Gibilterra 1
GT - Guatemala 1
IE - Irlanda 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
Totale 16.734
Città #
Woodbridge 962
Fairfield 941
Singapore 901
Ashburn 855
Houston 662
Jacksonville 623
Chandler 536
Ann Arbor 485
Santa Clara 442
Beijing 438
Hong Kong 387
Seattle 362
Wilmington 354
Dallas 309
Cambridge 285
Izmir 196
Munich 190
Nanjing 184
Los Angeles 158
New York 148
Princeton 125
San Diego 94
Boardman 88
Milan 82
São Paulo 75
Buffalo 74
Ho Chi Minh City 74
Helsinki 71
Mexico City 71
Shanghai 68
Bremen 61
Ferrara 58
Nanchang 53
Hefei 52
Shenyang 48
Hanoi 47
London 44
Hebei 41
Tianjin 40
Warsaw 40
Addison 37
Montreal 36
Changsha 35
Dong Ket 33
San Mateo 30
Jinan 28
Turku 28
Chicago 27
Denver 27
Chennai 25
Stockholm 25
Johannesburg 24
Atlanta 23
Auburn Hills 22
Mountain View 22
Tokyo 22
Brooklyn 21
Brussels 20
Jiaxing 20
The Dalles 19
Toronto 19
Phoenix 17
Verona 17
Moscow 16
Orem 16
Poplar 16
Kunming 15
Philadelphia 15
Rio de Janeiro 15
Zhengzhou 14
Augusta 13
Boston 13
Dearborn 13
Falkenstein 13
Frankfurt am Main 13
Tappahannock 13
Ankara 12
Norwalk 12
Redwood City 12
San Francisco 12
Brasília 10
Curitiba 10
Ningbo 10
Porto Alegre 10
Belo Horizonte 9
Biên Hòa 9
Charlotte 9
Guangzhou 9
Haiphong 9
Jakarta 9
Taizhou 9
Amsterdam 8
Dhaka 8
Falls Church 8
Hải Dương 8
Indiana 8
Leawood 8
Manchester 8
Salt Lake City 8
Ardabil 7
Totale 11.708
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 348
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 316
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 286
A cyclic peptide T analogue with high chemotactic activity 257
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 229
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 196
6-(hydroxyphenyl)imidazo[2,1-b]thiazoles as potential antiinflammatory agents: Effects on human neutrophil functions 195
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 193
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 191
Modulation of neutrophil functions by activated platelet release factors 189
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 188
A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs. 186
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxis 185
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 182
Ring-opened analogs of indomethacin affecting human neutrophil functions 179
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 178
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 178
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 176
An evaluation of fMLP pocket dimensions and features using formyltetrapeptides 176
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For‐Hse(Me)‐Leu‐Phe‐OMe 174
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 171
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 171
Conformational Aspects of Human Formyl-peptide Receptor Agonists 167
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 167
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 166
Attivita' tumoricida dei neutrofili 164
Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues 164
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 162
Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2 157
b-peptido sulfonamides. For-Met-Leu-Phe-OMe analogues containing taurine and chiral b-amino-ethansulfonic acid residues 156
Conformational aspects of human formylpeptide receptor antagonists 156
Differences arising in human neutrophil activation passing from N-formyl to N-acetyl-oligopeptides 155
Modified chemotactic peptides: Synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe 155
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 155
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 154
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 153
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 153
An exhaustive insight into the pocket charge features of the methionine receptor using fMLP analogs. 152
Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety 152
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 152
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 152
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 150
An exhaustive insight into the pocket cherge features of the methionine receptor using fMLP analogs. 144
Oligomeric formylpeptide activity on human neutrophils 144
Probing structural requirements of fMLP receptor: On the size of the hydrophobic pocket corresponding to residue 2 of the tripeptide 143
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 141
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 141
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 140
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 140
Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe 140
Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue 138
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 138
Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms 138
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 137
N-Benzyl-2-chloroindole-3-carboxylic acids as potential anti-inflammatory agents. Synthesis and screening for the effects on human neutrophil functions and on COX1/COX2 activity 137
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 135
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 135
HLA B51 antigen associated with neutrophil hyper-reactivity 135
Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T 134
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 134
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'(methylthio) ethyl] methionine residue 134
CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils 131
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: Synthesis and bioactivity 131
Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs 131
Synthesis and properties of chemotactic peptide analogs: II. HCO‐Met‐Leu‐Phe‐OMe analogs containing cyclic α,α‐disubstituted amino acids as Met and Phe mimicking residues 131
Protein kinase C mediates human neutrophil cytotoxicity 130
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 129
Synthesis and bioactivity of chemotactic tetrapeptides: FMLF-OMe analogues incorporating spacer aminoacids at the lateral positions 128
The importance of the methionine configuration in for-Met-Leu-Phe-OMe biological activities. 128
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 127
Conformation-activity relationship of peptide t and new pseudocyclic hexapeptide analogs 126
2-phenyl-1-arylcarbamoyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazoles 7-substituted as potential neutrophil chemotaxis inhibitors 126
alfa-Peptide/beta-sulfonamidopeptide hybrids: analogues of the chemotactic agent For-Met-Leu-Phe-OMe; 125
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes 125
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 125
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 124
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 123
Pseudopeptides containing the 2-hydrazonoacyl fragment: Analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe 121
Exploring the interest of 1,2-Dithiolane ring system in peptide chemistry. Synthesis of a chemotactic tripeptide and x-ray crystal structure of a 4-amino-1,2-dithiolane-4-carboxylic acid derivative 115
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 113
Antibody-independent cytoxicity against human erythroleukemic K 562 human cells by neutrophils 111
Interferon-gamma enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16 108
Valutazione funzionale dei leucociti. 107
NEW CHEMOTACTIC PEPTIDE ANALOGS WITH HIGH BIOLOGICAL ACTIVITY FOR HUMAN NEUTROPHILS 105
Effects of Synthetic Peptides on the Inflammatory Response and Their Therapeutic Potential. 102
FLOW CYTOMETRY STUDY OF CR1, CR3 AND GRANULE CONSTITUENTS IN NEUTROPHILS OF MDS PATIENTS AND HEALTHY CONTROLS: RELATIONSHIP WITH FUNCTIONAL ACTIVITIES AND DISEASE STATES 101
Solution structure of the amino acid sequence coded by the rarely expressed exon 26A of human elastin: The N-terminal region 100
Chemotactic effects of nociceptin/orphanin FQ on human monocytes are mediated by nop receptor activation 99
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 99
Peptide T revisited: Conformational mimicry of epitopes of anti-HIV proteins 98
Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells 97
null 96
NEUTROPHILS FROM PATIENTS WITH MYELODISPLASTIC SYNDROMES: RELATIONSHIP BETWEEN IMPAIRMENT OF GRANULAR CONTENTS, COMPLEMENT RECEPTORS, FUNCTIONAL ACTIVITIES AND DISEASE STATUS 94
Met-Ile-Phe-Leu derivates: full and partial agonist towards formyl peptide receptors of human neutrophils. 94
Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues. J.Pept.Sci, 18, 418-426, 2012. 93
null 92
null 92
null 90
Selective interaction of myelin basic protein and monoclonal antibody with leukocyte membrane 89
Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing ß-alanine or taurine at the central position 89
Totale 14.659
Categoria #
all - tutte 75.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.022
Totale 76.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021836 0 0 0 0 0 147 54 165 22 160 196 92
2021/20221.290 40 162 102 89 61 35 54 64 37 83 144 419
2022/20231.270 132 61 52 153 224 199 62 112 170 7 53 45
2023/2024517 69 66 31 14 27 106 23 51 9 3 4 114
2024/20252.531 67 30 183 72 349 253 138 154 407 274 343 261
2025/20264.235 763 553 704 1.062 1.069 84 0 0 0 0 0 0
Totale 16.841